Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications
Open Access
- 4 June 2015
- journal article
- review article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2015, 1-10
Abstract
Pancreatic adenocarcinoma is one of the deadliest human malignancies. Early detection is difficult and effective treatment is limited. Verifying the presence of micrometastatic dissemination and vessel invasion remains elusive, limiting radiological staging once this diagnosis is made. Diagnostic imaging provides independent tools to evaluate and characterize the biologic behavior of pancreatic cancer. Conventional anatomic imaging alone with either CT or MRI yields useful information on organ involvement but is limited in providing molecular and physiological information. Molecular imaging techniques such as PET or MRS provide information on metabolic and signaling pathways. Advanced MR sequences that target physiological parameters expand imaging options to characterize these tumors. By considering the parametric data from these three imaging approaches (anatomic, molecular, and physiological) we can better define specific tumor signatures. Such parametric characterization can provide insight into tumor metabolism, cellular density, protein expression, focal perfusion, and vascular permeability of these tumors. Radiogenomics research has already demonstrated ability to obtain information about cancer’s genotype and phenotype; this is without invasive procedures or surgery. Further advances in these areas of experimental imaging hold promise to enable future clinical advances in detection and therapy of pancreatic cancer.Keywords
This publication has 82 references indexed in Scilit:
- [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal MalignanciesPET Clinics, 2014
- Contrast-enhanced CT and diffusion-weighted MR imaging: Performance as a prognostic factor in patients with pancreatic ductal adenocarcinomaEuropean Journal of Radiology, 2014
- Imaging diagnosis of pancreatic cancer: A state-of-the-art reviewWorld Journal of Gastroenterology, 2014
- Diffusion‐weighted magnetic resonance imaging of pancreatic adenocarcinomas: Association with histopathology and tumor gradeJournal of Magnetic Resonance Imaging, 2010
- Diffusion-weighted MR Imaging of the LiverRadiology, 2010
- Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with18F-FDG PET,18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRIJournal of Nuclear Medicine, 2009
- PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma ModelsJournal of Nuclear Medicine, 2009
- Ultrasonography, Computed Tomography and Magnetic Resonance Imaging for Diagnosis and Determining Resectability of Pancreatic AdenocarcinomaJournal of Computer Assisted Tomography, 2005
- Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) —Usefulness and limitations in “clinical reality”—Annals of Nuclear Medicine, 2003
- Imaging of apoptosis (programmed cell death) with 99mTc annexin V.1999